1-3 of 3
Jeffrey Meshulam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

P B S-1086, a “Pan-Rel” Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells

Susan J Tudhope, BSc, PhD, Evan A Mulligan, BSc, PhD, Jill E Hunter, BSc, PhD, Geoffrey P Summerfield, MD, Scott Marshall, MD, Jonathan Wallis, MD, Helen Marr, Paul Evans, Chris Lowe, Barbara W Durkacz, BSc, PhD, Jie Zhang, PhD, Jeffrey Meshulam, BS, Kathryn Bobb, MS, Elaine Willmore, BSc, PhD
Journal: Blood
Blood (2012) 120 (21): 867.
https://doi.org/10.1182/blood.V120.21.867.867
Published: 2012
Journal Articles

Dual Inhibition of Canonical and Non-Canonical NF-KB Pathway Demonstrates Significant Anti-Tumor Activities in Multiple Myeloma (MM)

Claire Fabre, MD, PhD, Naoya Mimura, MD, PhD, Kathryn Bobb, MS, Gullu Gorgun, PhD, Diana D. Cirstea, MD, Yiguo Hu, PhD, Jiro Minami, MD, PhD, Hiroto Ohguchi, MD, PhD, Jie Zhang, PhD, Jeffrey Meshulam, BS, Constantine S. Mitsiades, MD, PhD, Paul G. Richardson, MD, Teru Hideshima, MD, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2011) 118 (21): 2902.
https://doi.org/10.1182/blood.V118.21.2902.2902
Published: 2011
Journal Articles

Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I–associated neurologic disease

Unsong Oh, Matthew J. McCormick, Dibyadeep Datta, Richard V. Turner, Kathryn Bobb, Dileep D. Monie, D. Robert Sliskovic, Yuetsu Tanaka, Jie Zhang, Jeffrey Meshulam, Steven Jacobson
Journal: Blood
Blood (2011) 117 (12): 3363–3369.
https://doi.org/10.1182/blood-2010-10-306571
Published: 2011